Reflujo gastroesofágico en el niño

EMC - Tratado de Medicina - Tập 26 - Trang 1-11 - 2022
R. Enaud1, E. Dobremez2, T. Lamireau1,3
1Unité de gastroentérologie et nutrition pédiatriques, Hôpital des enfants, CHU Bordeaux, Bordeaux, France
2Service de chirurgie pédiatrique, Hôpital des Enfants, CHU Bordeaux, Bordeaux, France
3Hôpital des enfants, Place Amélie-Raba-Léon, 33076 Bordeaux, France

Tài liệu tham khảo

Sherman, 2010, A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population, Arch Pediatr, 17, 1586, 10.1016/j.arcped.2010.08.030 Martin, 2002, Natural history and familial relationships of infant spilling to 9 years of age, Pediatrics, 109, 1061, 10.1542/peds.109.6.1061 Martigne, 2012, Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study, Eur J Pediatr, 171, 1767, 10.1007/s00431-012-1807-4 Rosen, 2018, J Pediatr Gastroenterol Nutr, 66, 516, 10.1097/MPG.0000000000001889 Sondeimer, 1980, Continuous pH monitoring of distal esophageal pH: a diagnostic test for a gastroesophageal reflux in infants, J Pediatr, 96, 804, 10.1016/S0022-3476(80)80546-4 Viola, 2004, Reflux gastro-œsophagien de l’enfant : quand proposer des explorations non endoscopiques ?, Arch Pediatr, 11, 668, 10.1016/j.arcped.2004.03.006 Loots, 2009, Addition of pH-impedance monitoring to standard pH monitoring increases the yield of symptom association analysis in infants and children with gastroesophageal reflux, J Pediatr, 15, 248, 10.1016/j.jpeds.2008.08.019 Wenzl, 2012, ESPGHAN EURO-PIG WorkingGroup Indications, methodology, and interpretation of combined esophageal impedance-pH monitoring in children: ESPGHAN EURO-PIG standard protocol, J Pediatr Gastroenterol Nutr, 55, 230, 10.1097/MPG.0b013e3182592b65 Olives, 2004, Indications de l’endoscopie digestive au cours du reflux gastro-œsophagien de l’enfant, Arch Pediatr, 11, 666, 10.1016/j.arcped.2004.03.088 Mattioli, 2004, Necessity for surgery in children with gastrooesophageal reflux and supraoesophageal symptoms, Eur J Pediatr Surg, 14, 7, 10.1055/s-2004-815773 Zerbib, 2010, Medical treatment of GORD. Emerging therapeutic targets and concepts, Best Pract Res Clin Gastroenterol, 24, 937, 10.1016/j.bpg.2010.08.009 Savarino, 2009, Proton pump inhibitors in GORD. An overview of their pharmacology, efficacy and safety, Pharmacol Res, 59, 135, 10.1016/j.phrs.2008.09.016 De Bruyne, 2018, Toxicity of long-term use of proton pump inhibitors in children, Arch Dis Child, 103, 78, 10.1136/archdischild-2017-314026 Gilger, 2004, Outcomes of surgical fundoplication in children, Clin Gastroenterol Hepatol, 2, 978, 10.1016/S1542-3565(04)00456-2 Diaz, 2005, Antireflux surgery outcomes in pediatric gastroesophageal reflux disease, Am J Gastroenterol, 100, 1844, 10.1111/j.1572-0241.2005.41763.x Lee, 2011, The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GRED in children, Arch Dis Child, 96, 9, 10.1136/adc.2010.188565 Afssaps Recommandations de bonne pratique : anti-sécrétoires gastriques chez l’enfant. Octobre 2008. HAS Commission de la transparence. Inexium. Avis du 21 octobre 2009. Chen, 2012, Proton pump inhibitor use in infants: FDA reviewer experience, J Pediatr Gastroenterol Nutr, 54, 8, 10.1097/MPG.0b013e31823890b4 Omari, 2007, Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux, J Pediatr Gastroenterol Nutr, 44, 41, 10.1097/01.mpg.0000252190.97545.07 Sopo, 2009, Does treatment with proton pump inhibitor for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD?. A systematic review, J Invest Allergol Clin Immunol, 19, 1 McMurray, 2001, Role of laryngoscopy, dual pH probe monitoring, and laryngeal mucosal biopsy in the diagnosis of pharyngoesophageal reflux, Ann Otol Rhinol Laryngol, 110, 299, 10.1177/000348940111000402 Chang, 2006, Gastro-esophageal reflux treatment for prolonged non-specific cough in children and adults, Cochrane Database Syst Rev, 4 Orenstein, 2009, Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease, J Pediatr, 154, 514, 10.1016/j.jpeds.2008.09.054 van der Pol, 2011, Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review, Pediatrics, 127, 925, 10.1542/peds.2010-2719 Mouterde, 2010, Reflux gastro-œsophagien (RGO) et inhibiteurs de la pompe à proton chez l’enfant : panacée ou abus ?, Arch Pediatr, 17, 739, 10.1016/S0929-693X(10)70086-5 Strobel, 1979, Correlation of esophageal lengths in children with heights: application of the Tuttle test with prior esophageal manometry, J Pediatr, 94, 81, 10.1016/S0022-3476(79)80361-3 Hochman, 2008, Previous wireless pH monitoring study overlooked, J Pediatr Gastroenterol Nutr, 46, 607, 10.1097/MPG.0b013e3181684caa 1992, A standardised protocol for the methodology of esophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux, J Pediatr Gastroenterol Nutr, 14, 467, 10.1097/00005176-199205000-00017 Zerbib, 2005, Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects, Aliment Pharmacol Ther, 22, 1011, 10.1111/j.1365-2036.2005.02677.x López-Alonso, 2006, Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux, Pediatrics, 118, e299, 10.1542/peds.2005-3140